Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · IEX Real-Time Price · USD
116.79
+1.05 (0.91%)
At close: Jul 19, 2024, 4:00 PM
117.29
+0.50 (0.43%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $8.10 billion as of July 22, 2024. Its market cap has increased by 45.52% in one year.
Market Cap
8.10B
Enterprise Value
7.94B
1-Year Change
45.52%
Ranking
Category
Stock Price
$116.79
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $8.10B, an increase of 4,424.88%. That is a compound annual growth rate of 52.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 8.10B | 90.64% |
| Dec 29, 2023 | 4.25B | 21.06% |
| Dec 30, 2022 | 3.51B | 79.37% |
| Dec 31, 2021 | 1.96B | 116.78% |
| Dec 31, 2020 | 902.10M | 12.06% |
| Dec 31, 2019 | 805.00M | 33.72% |
| Dec 31, 2018 | 602.00M | -21.51% |
| Dec 29, 2017 | 767.00M | 149.67% |
| Dec 30, 2016 | 307.20M | 188.72% |
| Dec 31, 2015 | 106.40M | -40.53% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Encompass Health | 8.59B |
| Bio-Rad Laboratories | 8.48B |
| Bio-Rad Laboratories | 8.33B |
| Chemed | 8.22B |
| Roivant Sciences | 8.13B |
| Intra-Cellular Therapies | 7.90B |
| Cerevel Therapeutics Holdings | 7.82B |
| The Ensign Group | 7.71B |